background
respiratori
infect
result
invas
respiratori
tract
mainli
virus
lead
caus
acut
morbid
individu
age
worldwid
peak
season
picornavirus
caus
episod
acut
nasopharyng
common
cold
frequent
manifest
acut
respiratori
infect
produc
restrict
activ
physician
consult
annual
viral
bacteri
sourc
respiratori
ill
object
articl
review
clinic
impact
outcom
picornavirusinduc
respiratori
infect
specif
popul
risk
complic
also
discuss
potenti
econom
impact
morbid
associ
picornavirusinduc
respiratori
infect
method
relev
literatur
identifi
search
medlin
ovid
intern
pharmaceut
abstract
lexisnexi
search
term
use
picornaviru
rhinoviru
enteroviru
viral
respiratori
infect
upper
respiratori
iqfect
diseas
burden
econom
cost
complic
asthma
copd
immunocompromis
elderli
otiti
media
sinus
addit
public
identifi
refer
list
retriev
articl
conclus
base
clinic
literatur
picornaviru
infect
associ
sever
morbid
well
consider
econom
societ
cost
futur
research
focu
identifi
pattern
ill
cost
associ
manag
infect
new
treatment
assess
term
abil
produc
desir
clinic
outcom
also
term
abil
reduc
burden
diseas
decreas
health
care
cost
improv
product
respiratori
infect
recogn
lead
caus
acut
morbid
individu
age
worldwid
develop
countri
morbid
associ
respiratori
infect
may
least
sever
industri
countri
infect
lead
caus
death
children
year
age
health
interview
survey
quantifi
ill
result
disabl
andor
physician
consult
us
popul
base
survey
annual
incid
acut
respiratori
infect
unit
state
exceed
rate
digest
condit
injuri
infectiveparasit
condit
combin
infect
may
result
invas
respiratori
tract
bacteria
virus
rare
case
infecti
agent
howev
virus
frequent
identifi
pathogen
viral
pathogen
primarili
associ
acut
respiratori
infect
includ
picomavirus
coronavirus
adenovirus
paraintluenza
virus
influenza
virus
respiratori
syncyti
virus
figur
picornavirus
larg
group
rna
virus
term
caus
acut
respiratori
infect
human
import
picornavirus
rhinovirus
enterovirus
picornavirus
contribut
significantli
incid
acut
respiratori
infect
studi
conduct
picornavirus
found
caus
episod
acut
nasopharyng
common
manifest
acut
respiratori
infect
individu
incid
acut
nasopharyng
adult
rang
case
per
year
children
case
per
although
picornavirusinduc
nasopharyng
often
refer
common
cold
morbid
associ
infect
trivial
fact
rhinovirusinduc
ill
common
produc
restrict
activ
physician
consult
annual
respiratori
ill
caus
virus
bacteria
articl
review
clinic
impact
outcom
associ
picomavirusinduc
respiratori
infect
specif
popul
risk
complic
secondari
infect
also
discuss
potenti
econom
impact
morbid
associ
picornavirusinduc
respiratori
infect
relev
literatur
identifi
search
medlin
ovid
intern
pharmaceut
abstract
lexisnexi
search
term
use
picnrnuviru
rhinoviru
enteroviru
respiruto
infect
upper
respiratori
infect
diseas
burden
econom
cost
complicut
asthma
copd
immunocompromis
elderli
otiti
media
sinus
addit
public
identifi
refer
list
retriev
articl
rhinoviru
infect
associ
pronounc
clinic
manifest
respiratori
infect
viral
etiolog
mani
human
rhinoviru
infect
result
symptomat
respiratori
episod
character
rhinorrhea
nasal
obstruct
cough
hoars
median
durat
ill
young
adult
day
howev
symptom
may
last
week
one
quarter
case
durat
ill
may
even
longer
children
peak
incid
rhinoviru
infect
earli
fall
midto
late
springjo
figur
younger
children
appear
suscept
viral
respiratori
infect
demonstr
fact
preschool
children
respiratori
infect
per
year
fact
outbreak
new
viru
strain
three
fourth
children
nurseri
school
also
secondari
attack
rate
famili
member
observ
rang
depend
immun
statu
expos
high
incid
viral
respiratori
infect
like
due
larg
number
rhinoviru
type
fact
immun
type
specif
short
durat
reason
among
other
role
rhinovirus
overshadow
enterovirus
also
contribut
morbid
viral
respiratori
infect
estim
enterovirus
infect
million
peopl
annual
episod
enterovirusinduc
respiratori
infect
seen
throughout
year
howev
promin
respiratori
syndrom
caus
pathogen
occur
children
summer
month
enterovir
infect
typic
result
nonspecif
febril
ill
complic
respiratori
symptom
although
viral
respiratori
infect
due
picornavirus
appear
selflimit
healthi
adult
increasingli
implic
acut
infecti
exacerb
ill
highrisk
popul
technolog
advanc
polymeras
chainreact
test
made
viru
identif
sensit
readili
avail
turn
made
possibl
identifi
specif
patient
popul
eg
elderli
infant
immunocompromis
person
particularli
suscept
picornaviru
infect
infecti
episod
typic
significantli
increas
use
health
care
resourc
addit
advanc
technolog
confirm
result
earlier
studi
demonstr
signific
rhinovirus
caus
predispos
patient
otiti
media
sinus
exacerb
chronic
respiratori
diseas
asthma
cystic
fibrosi
chronic
obstruct
pulmonari
diseas
copd
asthma
estim
affect
million
peopl
popul
unit
state
result
million
day
restrict
activ
hospit
annual
estim
cost
treat
asthma
billion
cost
associ
emerg
depart
visit
hospit
death
respiratori
infect
caus
picornavirus
believ
major
contributor
asthma
exacerb
particularli
children
asthmat
children
appear
experi
significantli
greater
number
viral
respiratori
infect
compar
nonasthmat
children
acut
asthma
exacerb
children
thought
relat
viral
respiratori
common
caus
infect
rhinovirus
recov
respiratori
tract
onset
asthma
attack
suggest
viru
may
initi
factor
attack
sever
studi
identifi
rhinoviru
pathogen
commonli
associ
asthma
year
rake
et
conduct
crosssect
studi
examin
preval
respiratori
virus
children
present
emerg
depart
wheez
episod
found
respiratori
virus
present
children
year
age
children
year
age
rhinoviru
predomin
pathogen
isol
children
year
age
indic
major
wheez
episod
age
group
may
associ
rhinovirus
preval
rhinovirus
asthmat
children
investig
johnston
et
trial
author
evalu
children
age
year
respiratori
symptom
wheez
andor
cough
decreas
peak
expiratori
flow
rate
pefr
respiratori
virus
two
third
rhinovirus
detect
patient
viral
respiratori
infect
implic
episod
upper
respiratori
symptom
episod
reduct
pefr
median
reduct
pefr
lmin
median
durat
declin
pefr
day
base
result
author
report
asthma
exacerb
schoolag
children
appear
associ
viral
respiratori
infect
primarili
rhinovirus
adult
asthmat
patient
howev
beasley
et
found
preval
viral
respiratori
infect
adult
sever
asthma
mild
exacerb
asthma
nicholson
et
conduct
longitudin
trial
asthmat
adult
age
year
evalu
episod
respiratori
ill
year
averag
durat
asthma
patient
popul
year
thirtyeight
percent
patient
previous
hospit
asthma
investig
found
subject
asthma
exacerb
occur
symptomat
cold
symptomat
cold
associ
symptom
asthma
find
suggest
acut
respiratori
infect
may
commonli
link
exacerb
asthma
adult
children
studi
clinic
episod
respiratori
ill
associ
object
evid
asthma
exacerb
decreas
pefr
lmin
sixtythre
percent
laboratoryconfirm
acut
respiratori
infect
found
caus
rhinovirus
clinic
episod
respiratori
ill
associ
object
asthma
exacerb
patient
consult
gener
practition
episod
requir
oral
steroid
requir
nebul
prescrib
antibiot
addit
clinic
impact
rhinovirus
asthma
impact
medic
resourc
use
also
demonstr
teichtahl
et
al
compar
incid
respiratori
infect
patient
admit
respiratori
medic
unit
acut
asthma
control
subject
admit
surgic
unit
elect
surgeri
twentynin
patient
admit
asthma
exacerb
evid
respiratori
infect
compar
control
group
p
asthma
patient
confirm
evid
viral
infect
rhinoviru
infect
signific
mortal
result
viral
respiratori
infect
routin
observ
elderli
although
mortal
result
specif
rhinovir
respiratori
infect
demonstr
consider
morbid
associ
infect
studi
nicholson
et
adult
age
year
monitor
episod
viral
upper
respiratori
tract
infect
annual
incid
viral
respiratori
infect
found
per
patient
total
pathogen
identifi
episod
specimen
avail
pathogen
identifi
rhinovirus
patient
rhinoviru
sole
pathogen
isol
patient
lower
respiratori
tract
involv
median
durat
ill
patient
day
patient
lower
respiratori
tract
involv
restrict
normal
activ
eg
clean
groceri
shop
bedridden
total
patient
sought
medic
attent
antibiot
prescrib
altogeth
patient
hospit
die
exacerb
copd
rhinoviru
infect
author
report
overal
burden
rhinoviru
infect
greater
virus
typic
associ
signific
morbid
mortal
influenza
second
studi
assess
impact
rhinoviru
infect
elderli
focus
outbreak
respiratori
ill
among
patient
longterm
care
facil
x
specimen
throat
nasopharynx
patient
obtain
cultur
cultur
posit
rhinoviru
patient
rhinovirusposit
cultur
upper
respiratori
tract
symptom
system
symptom
gastrointestin
symptom
lower
respiratori
tract
symptom
sever
diseas
progress
found
rhinovirusinfect
patient
concomit
copd
five
patient
copd
requir
pharmacolog
bronchodil
transfer
facil
declin
respiratori
function
die
respiratori
failur
find
indic
outbreak
rhinoviru
infect
nurs
home
consid
potenti
seriou
studi
indic
commun
respiratori
diseas
complic
otiti
media
although
percentag
may
seem
insignific
high
frequenc
respiratori
infect
mean
larg
number
patient
affect
conserv
estim
place
incid
viral
respiratori
infect
unit
state
infect
per
person
per
year
base
data
estim
million
peopl
unit
state
experi
viral
respiratori
infect
year
million
infect
complic
otiti
media
almost
million
complic
sinus
new
technolog
permit
accur
identif
viral
pathogen
probabl
reveal
frequenc
viral
induc
infect
even
higher
viral
pathogen
precursor
case
otiti
media
sinus
origin
estim
howev
research
necessari
estim
patient
otiti
media
also
symptom
upper
respiratori
tract
infect
probabl
result
primari
viral
correl
support
fact
patient
otiti
media
detect
viru
nasopharynx
detect
viru
middl
virus
also
complic
cours
recoveri
patient
otiti
media
recent
studi
virus
middl
ear
implic
appar
failur
antibiot
treatment
complic
respons
treatment
studi
patient
combin
viral
bacteri
otiti
media
presenc
rhinoviru
associ
higher
failur
rate
antibiot
therapi
respiratori
syncyti
viru
parainfluenza
viru
influenza
viru
rhinoviru
identifi
potenti
pathogen
case
communityacquir
although
evid
virus
contribut
develop
sinus
exact
role
remain
undefin
studi
turner
et
al
healthi
adult
experiment
infect
rhinoviru
magnet
reson
imag
chang
observ
paranas
sinus
subject
relationship
viral
infect
sinus
investig
studi
evalu
natur
acquir
acut
nasopharyng
studi
sinu
abnorm
detect
comput
tomographi
adult
patient
week
observ
spontan
resolut
abnorm
occur
almost
patient
popul
although
role
picornavirus
seriou
diseas
lower
respiratori
tract
determin
definit
without
extens
sampl
lower
respiratori
tract
recent
studi
point
import
picornaviru
infect
diseas
process
particular
patient
popul
infant
bronchopulmonari
dysplasia
significantli
increas
risk
acut
episod
sever
viral
respiratori
infect
studi
daili
preterm
infant
bronchopulmonari
dysplasia
requir
rehospit
common
caus
upper
respiratori
tract
infect
wherea
indic
respiratori
syncyti
viru
pathogen
commonli
isol
patient
demonstr
rhinoviru
make
substanti
contribut
fact
none
studi
use
assay
suitabl
identifi
rhinovirus
role
agent
may
underestim
chidekel
et
studi
patient
case
histori
bronchopulmonari
dysplasia
averag
month
identifi
case
sever
lower
respiratori
tract
infect
associ
rhinovirus
patient
case
requir
hospit
mean
durat
day
admit
intens
care
unit
patient
rhinovir
respiratori
infect
requir
addit
longterm
medic
therapi
suggest
rhinovirus
last
clinic
implic
patient
cystic
fibrosi
also
increas
risk
complic
viral
respiratori
infect
fact
pulmonari
exacerb
preced
viral
respiratori
infect
collinson
et
ai
record
episod
acut
nasopharyng
month
children
cystic
fibrosi
age
month
year
translat
annual
incid
cultur
avail
episod
caus
pathogen
identifi
rhinoviru
episod
viral
respiratori
infect
associ
acut
decreas
pulmonari
function
increas
rate
diseas
progress
predisposit
bacteri
pulmonari
infect
lower
respiratori
tract
infect
common
complic
viral
respiratori
infect
immunocompromis
one
studi
commonli
identifi
caus
viral
respiratori
infect
immunocompromis
patient
includ
cytomegaloviru
herp
simplex
viru
varicellazost
viru
howev
virus
picornavirus
also
implic
studi
certain
techniqu
use
capabl
detect
rhinoviru
whether
virus
accur
repres
studi
find
immunocompromis
patient
risk
develop
seriou
lifethreaten
diseas
result
viral
infect
respiratori
tract
studi
rabella
et
rhinovirus
enterovirus
identifi
viral
pathogen
immunosuppress
patient
ie
patient
infect
hiv
bone
marrow
transplant
recipi
organ
transplant
recipi
patient
hematolog
malign
suspect
respiratori
infect
januari
decemb
picornaviru
infect
associ
respiratori
failur
patient
requir
mechan
ventil
clinic
cours
result
pneumonia
studi
conduct
univers
texa
md
anderson
cancer
center
mdacc
case
picornaviru
infect
identifi
adult
patient
leukemia
bone
marrow
transplant
recipi
picornaviru
infect
test
found
caus
rhinovirus
sever
patient
infect
progress
pneumonia
appear
bacteri
fungal
origin
howev
patient
clinic
cours
consist
viral
pneumonia
die
unexplain
interstiti
pneumonia
retrospect
followup
studi
blood
bone
marrow
transplant
recipi
symptom
upper
respiratori
tract
rhinoviru
identifi
caus
pathogen
patient
eight
patient
develop
progress
pneumonia
result
death
autopsi
patient
demonstr
interstiti
pneumon
andor
chang
acut
respiratori
distress
syndrom
death
attribut
progress
viral
pneumonia
basi
histolog
featur
ant
mortem
isol
rhinoviru
lower
respiratori
tract
site
prospect
studi
conduct
evalu
adult
bone
marrow
transplant
recipi
hospit
acut
viral
respiratori
infect
demonstr
identifi
infect
due
picornavirus
patient
rhinoviru
implic
caus
pathogen
develop
complic
pneumonia
die
result
find
autopsi
perform
patient
consist
progress
viral
pneumonia
third
trial
mdacc
investig
acut
respiratori
ill
hospit
patient
leukemia
found
viral
infect
caus
picornavirus
togeth
result
studi
demonstr
immunocompromis
host
increas
risk
seriou
picornaviru
infect
potenti
result
death
although
econom
impact
picornaviru
infect
pronounc
atrisk
popul
describ
infect
signific
econom
impact
gener
popul
well
picornaviru
infect
manifest
primarili
acut
nasopharyng
accord
estim
nation
center
health
million
case
common
cold
requir
medic
attent
result
million
day
restrict
activ
even
signific
econom
product
perspect
acut
nasopharyng
caus
million
lost
workday
adult
age
year
million
lost
school
day
children
age
year
also
import
employ
perspect
fact
employe
miss
day
work
ill
stay
home
care
sick
children
product
also
diminish
employe
come
work
picornavirusinduc
respiratori
infect
compromis
qualiti
life
associ
infect
turn
neg
effect
product
furthermor
mani
medic
current
use
palli
treatment
respiratori
symptom
caus
drowsi
may
diminish
effici
product
workplac
final
respiratori
picornaviru
infect
easili
transmit
person
proxim
infect
individu
employe
like
becom
infect
result
addit
loss
product
factor
affect
product
qualiti
life
increasingli
import
today
health
care
environ
analys
need
better
quantifi
impact
respiratori
picornaviru
infect
overal
health
care
popul
date
direct
use
health
care
resourc
associ
viral
respiratori
ill
gener
popul
investig
comprehens
current
literatur
focus
primarili
atrisk
popul
data
indic
use
emerg
depart
hospit
servic
exacerb
complic
caus
picomaviru
infect
major
factor
econom
impact
respiratori
infect
within
atrisk
subpopul
asthma
patient
elderli
highrisk
patient
diseas
lower
respiratori
tract
cystic
fibrosi
patient
immunocompromis
patient
patient
sinus
otiti
media
except
physician
offic
visit
antibiot
use
account
major
econom
impact
econom
impact
picornaviru
infect
illustr
find
asthma
exacerb
link
rhinoviru
infect
children
adult
hospit
asthma
statist
appli
averag
asthmarel
hospit
per
year
involv
children
ls
rhinoviru
infect
respons
estim
hospit
annual
base
figur
averag
cost
per
hospit
asthma
exacerb
cost
hospit
due
rhinovirusinduc
asthma
exacerb
would
million
annual
prospect
econom
analysi
hospit
due
respiratori
infect
asthmat
popul
remain
conduct
marker
econom
impact
rhinovir
respiratori
infect
asthmat
popul
well
defin
cost
associ
hospit
factor
use
health
care
resourc
medic
physician
offic
visit
product
qualiti
life
work
school
absente
measur
signific
extent
evalu
variabl
crucial
establish
true
econom
burden
viral
respiratori
infect
asthmat
popul
patient
picornaviru
infect
high
risk
complic
age
infant
elderli
lower
respiratori
tract
involv
patient
copd
immun
statu
cystic
fibrosi
patient
immunocompromis
patient
constitut
addit
popul
hospit
emerg
depart
use
greatest
contributor
overal
cost
literatur
describ
review
illustr
definit
link
picornaviru
infect
increas
health
care
use
popul
howev
overal
pattern
resourc
use
cost
ill
defin
addit
signific
morbid
associ
picornaviru
infect
clinic
literatur
infect
also
substanti
econom
societ
implic
magnitud
implic
yet
well
defin
futur
research
focu
identifi
pattern
ill
cost
associ
manag
infect
abil
determin
cost
associ
viral
respiratori
infect
particularli
import
evalu
new
treatment
view
term
abil
produc
desir
clinic
outcom
also
term
abil
reduc
burden
diseas
decreas
health
care
cost
improv
product
acknowledg
support
articl
provid
viropharma
inc
exton
pennsylvania
